BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10546132)

  • 1. [Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
    Laurenzi F; Avella A; Adinolfi E; Dini P
    G Ital Cardiol; 1999 Oct; 29(10):1190-4. PubMed ID: 10546132
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden death due to cardiac arrhythmias.
    Huikuri HV; Castellanos A; Myerburg RJ
    N Engl J Med; 2001 Nov; 345(20):1473-82. PubMed ID: 11794197
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk].
    Ducceschi V; Sarubbi B; Esposito R; Manzo G; Mayer MS; Santangelo L; Iacono A
    Cardiologia; 1995 May; 40(5):355-60. PubMed ID: 8529247
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.
    Kruger A; Aronow WS; Lai H; Desai H; Singla A; Frishman WH; Cohen M; Sorbera C
    Am J Ther; 2009; 16(4):323-5. PubMed ID: 19617719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
    Seidl K; Hauer B; Schwick N; Buechele T; Schilling I; Senges J
    Dtsch Med Wochenschr; 1995 May; 120(18):656-60. PubMed ID: 7750434
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of ventricular arrhythmias - a contemporary perspective].
    Grönefeld GC; Hohnloser SH
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544
    [No Abstract]   [Full Text] [Related]  

  • 9. A bridge, but to where?
    Sweeney MO
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):584-6. PubMed ID: 12875417
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator].
    Tiroke A; Ganeeva ON
    Kardiologiia; 2003; 43(6):54-8. PubMed ID: 12891312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden death prevention with implantable devices.
    Passman R; Kadish A
    Circulation; 2007 Jul; 116(5):561-71. PubMed ID: 17664385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Usefulness of the implantable cardiodefibrillator (ICD) in the prevention of sudden death. Results of evidence based medicine].
    González CM
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-44-S2-46. PubMed ID: 17972377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of arrhythmia in myocardial infarct (secondary prevention)].
    Gertsch M
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1181-7. PubMed ID: 2877483
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A; Epstein AE; Herre JM; Klein RC; Platia EV; Wilkoff B; Ledingham RB; Greene HL; Hallstrom AP;
    Am J Cardiol; 2005 Jun; 95(12):1431-5. PubMed ID: 15950565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ventricular arrhythmias in heart failure: drugs or devices.
    Gambhir DS
    Indian Heart J; 1998; 50(5):507-10. PubMed ID: 10052273
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 19. Three questions for evidence-based cardiac electrophysiology.
    Kramer DB; Josephson ME
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):704-9. PubMed ID: 21081751
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complex and asymptomatic hyperkinetic ventricular arrhythmias: a daily difficult decision problem].
    G Ital Cardiol; 1994 Oct; 24(10):1333-9. PubMed ID: 7835567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.